mavoric trial: mogamulizumab for r/r ctc
Published 5 years ago • 259 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
0:59
mavoric: mogamulizumab improves pfs for ctcl
-
0:40
mavoric: long-term clinical benefit of mogamulizumab in patients with ctcl
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
0:54
mogamulizumab-associated rash in ctcl
-
13:13
expert perspectives: the mavoric trial
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
0:58
mogamulizumab: an exciting antibody for autoimmunity
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
11:47
petscan results. warning...not what we hoped for.
-
4:21
lymphoma: diagnosis, stages, treatment and life afterwards
-
54:43
closed caption version - wm basics diagnostics, understanding lab tests, symptoms
-
1:46
methods to access the clinical efficacy of mogamulizumab
-
1:47
trials exploring the safety and efficacy of modakafusp alfa in r/r multiple myeloma: iinnovate
-
1:06
pirtobrutinib in r/r mzl: insights from the bruin trial
-
1:17
globryte: investigating glofitamab monotherapy in patients with r/r mcl
-
1:15
hello tellomak: new trial for t-cell lymphoma
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
1:58
mavoric trial in cutaneous t-cell lymphoma
-
2:05
novel therapies on the horizon for cutaneous t-cell lymphoma
-
1:45
a phase i/ii trial of glofitamab monotherapy in r/r mcl
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
1:38
the safety and efficacy of belantamab mafodotin in r/r multiple myeloma in the real world